Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Optical control of targeted protein degradation
Martin Reynders, Dirk Trauner
Cell chemical biology (2021) Vol. 28, Iss. 7, pp. 969-986
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Protein degraders enter the clinic — a new approach to cancer therapy
Deborah Chirnomas, Keith R. Hornberger, Craig M. Crews
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 4, pp. 265-278
Closed Access | Times Cited: 335
Strategies for designing proteolysis targeting chimaeras (PROTACs)
Shipeng He, Guoqiang Dong, Junfei Cheng, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 3, pp. 1280-1342
Closed Access | Times Cited: 74
Self-Assembled Nano-PROTAC Enables Near-Infrared Photodynamic Proteolysis for Cancer Therapy
Weishan Wang, Chenghong Zhu, Bin Zhang, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 30, pp. 16642-16649
Closed Access | Times Cited: 44
Rational Design for Nitroreductase (NTR)-Responsive Proteolysis Targeting Chimeras (PROTACs) Selectively Targeting Tumor Tissues
Shi Shi, Yu Du, Yi Zou, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 6, pp. 5057-5071
Closed Access | Times Cited: 66
Inducible Degradation of Oncogenic Nucleolin Using an Aptamer-Based PROTAC
Miao Chen, Ping Zhou, Yun Kong, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 2, pp. 1339-1348
Closed Access | Times Cited: 40
PROTACs: Emerging Targeted Protein Degradation Approaches for Advanced Druggable Strategies
Nuwayo Ishimwe Sincere, Krishnan Anand, Sumel Ashique, et al.
Molecules (2023) Vol. 28, Iss. 10, pp. 4014-4014
Open Access | Times Cited: 38
Stimuli‐Responsive PROTACs for Controlled Protein Degradation
Keli An, Xuqian Deng, Hongli Chi, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 39
Closed Access | Times Cited: 33
Leveraging aptamers for targeted protein degradation
Zhihao Yang, Qiuxiang Pang, Jun Zhou, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 11, pp. 776-785
Closed Access | Times Cited: 23
Photoswitchable PROTACs for Reversible and Spatiotemporal Regulation of NAMPT and NAD+
Junfei Cheng, Jing Zhang, Shipeng He, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 12
Closed Access | Times Cited: 8
Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP-PROTACs)
Qisi Zhang, Cyrille S. Kounde, Milon Mondal, et al.
Chemical Communications (2022) Vol. 58, Iss. 78, pp. 10933-10936
Open Access | Times Cited: 28
Progress of small molecules for targeted protein degradation: PROTACs and other technologies
Hongyi Zhao, Minhang Xin, San‐Qi Zhang
Drug Development Research (2023) Vol. 84, Iss. 2, pp. 337-394
Closed Access | Times Cited: 16
Options to Improve the Action of PROTACs in Cancer: Development of Controlled Delivery Nanoparticles
Alberto Juan, María del Mar Noblejas‐López, María Arenas-Moreira, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 22
TACkling Cancer by Targeting Selective Protein Degradation
María del Mar Noblejas‐López, David Tébar-García, Raquel López-Rosa, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2442-2442
Open Access | Times Cited: 11
Covalent Affibody‐Molecular Glue Drug Conjugate Nanoagent for Proximity‐Enabled Reactive Therapeutics
Wenhui Gao, Xiaoyuan Yang, Qingrong Li, et al.
Advanced Science (2025)
Open Access
Targeted protein degradation with small molecules for cancer immunotherapy
Zichao Yang, Jianwei Xu, Xixiang Yang, et al.
Asian Journal of Pharmaceutical Sciences (2025), pp. 101058-101058
Open Access
Emerging Strategies in Proteolysis-Targeting Chimeras (PROTACs): Highlights from 2022
T. N. Rekha, Dongyun Shin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5190-5190
Open Access | Times Cited: 10
Next steps for targeted protein degradation
Mackenzie W. Krone, Craig M. Crews
Cell chemical biology (2024)
Closed Access | Times Cited: 3
Novel Design Strategies to Enhance the Efficiency of Proteolysis Targeting Chimeras
Chunlong Zhao, Frank J. Dekker
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 9, pp. 710-723
Open Access | Times Cited: 16
Mechanistic Basis for Red Light Switching of Azonium Ions
Miroslav Medveď, Mariangela Di Donato, Wybren Jan Buma, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 36, pp. 19894-19902
Open Access | Times Cited: 8
Azobenzene Photoswitches in Proteolysis Targeting Chimeras: Photochemical Control Strategies and Therapeutic Benefits
Arvind Negi, Charline Kieffer, Anne Sophie Voisin‐Chiret
ChemistrySelect (2022) Vol. 7, Iss. 23
Open Access | Times Cited: 13
Modular Development of Enzyme-Activatable Proteolysis Targeting Chimeras for Selective Protein Degradation and Cancer Targeting
Yanchi Chen, Lina Zhang, Lincheng Fang, et al.
JACS Au (2024) Vol. 4, Iss. 7, pp. 2564-2577
Open Access | Times Cited: 2
Synthesis, SAR, and application of JQ1 analogs as PROTACs for cancer therapy
Soumik De, Raghaba Sahu, Shubhendu Palei, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117875-117875
Closed Access | Times Cited: 2
Light-Activating PROTACs in Cancer: Chemical Design, Challenges, and Applications
Arvind Negi, Kavindra Kumar Kesari, Anne Sophie Voisin‐Chiret
Applied Sciences (2022) Vol. 12, Iss. 19, pp. 9674-9674
Open Access | Times Cited: 11
Development of visible-light-activatable photocaged PROTACs
Weizhi Weng, Gang Xue, Zhengying Pan
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116062-116062
Closed Access | Times Cited: 6
E3 ubiquitin ligases and deubiquitinases in colorectal cancer: Emerging molecular insights and therapeutic opportunities
Sunny Kumar, Malini Basu, Mrinal K. Ghosh
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2024) Vol. 1871, Iss. 8, pp. 119827-119827
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top